Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CCAP NYSE:HQL NYSE:IFN NYSE:JHS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCCAPCrescent Capital BDC$13.55-0.4%$13.00$11.80▼$17.02$502.78M0.59188,465 shs81,528 shsHQLabrdn Life Sciences Investors$18.13+1.0%$16.93$11.92▼$18.28$545.83M0.7793,951 shs96,437 shsIFNIndia Fund$12.10+0.6%$11.95$10.84▼$16.95$512.68M0.71131,204 shs135,847 shsJHSJohn Hancock Income Securities Trust$11.180.0%$11.15$10.74▼$12.09$140.47M0.5126,335 shs17,934 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCCAPCrescent Capital BDC0.00%-0.15%+8.54%-5.56%-14.41%HQLabrdn Life Sciences Investors0.00%+2.55%+4.51%+6.59%+47.74%IFNIndia Fund0.00%-0.13%+4.16%-14.33%-24.03%JHSJohn Hancock Income Securities Trust0.00%+0.22%+0.44%-4.48%-0.27%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCCAPCrescent Capital BDC$13.55-0.4%$13.00$11.80▼$17.02$502.78M0.59188,465 shs81,528 shsHQLabrdn Life Sciences Investors$18.13+1.0%$16.93$11.92▼$18.28$545.83M0.7793,951 shs96,437 shsIFNIndia Fund$12.10+0.6%$11.95$10.84▼$16.95$512.68M0.71131,204 shs135,847 shsJHSJohn Hancock Income Securities Trust$11.180.0%$11.15$10.74▼$12.09$140.47M0.5126,335 shs17,934 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCCAPCrescent Capital BDC0.00%-0.15%+8.54%-5.56%-14.41%HQLabrdn Life Sciences Investors0.00%+2.55%+4.51%+6.59%+47.74%IFNIndia Fund0.00%-0.13%+4.16%-14.33%-24.03%JHSJohn Hancock Income Securities Trust0.00%+0.22%+0.44%-4.48%-0.27%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCCAPCrescent Capital BDC 2.71Moderate Buy$15.5014.39% UpsideHQLabrdn Life Sciences Investors 0.00N/AN/AN/AIFNIndia Fund 0.00N/AN/AN/AJHSJohn Hancock Income Securities Trust 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest JHS, HQL, CCAP, and IFN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/16/2026CCAPCrescent Capital BDC Keefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$15.50 ➝ $15.003/30/2026CCAPCrescent Capital BDC B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$13.502/27/2026CCAPCrescent Capital BDC Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$14.00 ➝ $13.002/10/2026CCAPCrescent Capital BDC Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold(Data available from 5/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCCAPCrescent Capital BDC$167.29M2.99$1.71 per share7.92$19.09 per share0.71HQLabrdn Life Sciences InvestorsN/AN/AN/AN/AN/AN/AIFNIndia FundN/AN/AN/AN/AN/AN/AJHSJohn Hancock Income Securities TrustN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCCAPCrescent Capital BDC$34.51M$0.9414.418.74N/A20.64%9.32%4.07%5/13/2026 (Estimated)HQLabrdn Life Sciences InvestorsN/AN/AN/AN/AN/AN/AN/AN/AN/AIFNIndia FundN/AN/AN/AN/AN/AN/AN/AN/AN/AJHSJohn Hancock Income Securities TrustN/AN/AN/AN/AN/AN/AN/AN/AN/ALatest JHS, HQL, CCAP, and IFN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026CCAPCrescent Capital BDC$0.41N/AN/AN/A$39.58 millionN/A2/25/2026Q4 2025CCAPCrescent Capital BDC$0.44$0.45+$0.01$0.23$39.83 million$19.05 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCCAPCrescent Capital BDC$1.6812.40%+2.22%178.72%1 YearsHQLabrdn Life Sciences Investors$1.9110.54%N/AN/AN/AIFNIndia Fund$2.2018.19%N/AN/AN/AJHSJohn Hancock Income Securities Trust$0.615.46%N/AN/AN/ALatest JHS, HQL, CCAP, and IFN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/25/2026CCAPCrescent Capital BDCquarterly$0.4213.83%3/31/20263/31/20264/15/20262/10/2026HQLabrdn Life Sciences Investorsquarterly$0.5613.36%2/20/20262/20/20263/31/20262/10/2026IFNIndia Fundquarterly$0.906013.25%2/20/20262/20/20263/31/20263/2/2026JHSJohn Hancock Income Securities Trustquarterly$0.13775.01%3/12/20263/12/20263/31/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCCAPCrescent Capital BDC1.241.221.22HQLabrdn Life Sciences InvestorsN/AN/AN/AIFNIndia FundN/AN/AN/AJHSJohn Hancock Income Securities TrustN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCCAPCrescent Capital BDC49.46%HQLabrdn Life Sciences Investors32.21%IFNIndia Fund10.76%JHSJohn Hancock Income Securities TrustN/AInsider OwnershipCompanyInsider OwnershipCCAPCrescent Capital BDC1.23%HQLabrdn Life Sciences Investors10.06%IFNIndia FundN/AJHSJohn Hancock Income Securities TrustN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCCAPCrescent Capital BDCN/A36.97 million36.51 millionNot OptionableHQLabrdn Life Sciences InvestorsN/A30.41 million27.35 millionNot OptionableIFNIndia Fund21,00042.65 millionN/ANot OptionableJHSJohn Hancock Income Securities TrustN/A12.56 millionN/ANot OptionableJHS, HQL, CCAP, and IFN HeadlinesRecent News About These CompaniesJohn Hancock Income Securities Trust (NYSE:JHS) Share Price Passes Above 50-Day Moving Average - What's Next?May 5, 2026 | marketbeat.comJohn Hancock Income Securities Trust (NYSE:JHS) Sees Significant Increase in Short InterestApril 27, 2026 | marketbeat.comJohn Hancock Income Securities Trust (NYSE:JHS) Trading Down 0.4% - Here's What HappenedApril 20, 2026 | marketbeat.comJohn Hancock Strategic Income Opportunities Fund Q4 2025 CommentaryMarch 27, 2026 | seekingalpha.comJOHN HANCOCK CLOSED-END FUNDS DECLARE QUARTERLY DISTRIBUTIONSMarch 2, 2026 | prnewswire.comJohn Hancock Income Securities Trust (NYSE:JHS) Trades Flat in NYSEDecember 13, 2025 | kalkinemedia.comKJohn Hancock Balanced Fund Q3 2025 CommentaryNovember 20, 2025 | seekingalpha.comJOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATANovember 10, 2025 | prnewswire.comJohn Hancock Income Securities Trust cuts quarterly distribution to $0.1421September 3, 2025 | msn.comJohn Hancock Income Securities Share Price (JHS.US)June 19, 2025 | lse.co.ukJOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATAMay 13, 2025 | prnewswire.com1607 Capital Partners, LLC Increases Stake in John Hancock Income Securities TrustMarch 4, 2025 | gurufocus.comJOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATAFebruary 25, 2025 | prnewswire.com1607 Capital Partners, LLC Expands Stake in John Hancock Income Securities TrustFebruary 13, 2025 | gurufocus.comJohn Hancock Income Securities Trust (NYSE:JHS) Insider William K. Bacic Buys 911 Shares of StockJanuary 16, 2025 | insidertrades.comLong Term Trading Analysis for (JHS)January 5, 2025 | news.stocktradersdaily.comNJohn Hancock Income Securities Trust (NYSE:JHS) Insider Acquires $11,299.40 in StockDecember 27, 2024 | insidertrades.comJohn Hancock Income Securities Trust sees $11,301 in stock purchasesDecember 26, 2024 | investing.com(JHS) On The My Stocks PageDecember 5, 2024 | news.stocktradersdaily.comNTrend Tracker for (JHS)November 3, 2024 | news.stocktradersdaily.comNLearn to Evaluate (JHS) using the ChartsOctober 23, 2024 | news.stocktradersdaily.comNNew MarketBeat Followers Over TimeMedia Sentiment Over TimeJHS, HQL, CCAP, and IFN Company DescriptionsCrescent Capital BDC NASDAQ:CCAP$13.55 -0.05 (-0.37%) Closing price 05/8/2026 04:00 PM EasternExtended Trading$13.56 +0.01 (+0.07%) As of 05/8/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.abrdn Life Sciences Investors NYSE:HQL$18.13 +0.18 (+1.00%) Closing price 05/8/2026 03:58 PM EasternExtended Trading$18.18 +0.05 (+0.28%) As of 05/8/2026 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.India Fund NYSE:IFN$12.10 +0.08 (+0.62%) Closing price 05/8/2026 03:58 PM EasternExtended Trading$12.07 -0.03 (-0.22%) As of 05/8/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The India Fund, Inc. is a close ended equity mutual fund launched and managed by Aberdeen Standard Investments (Asia) Limited. The fund invests in public equity markets of India. It seeks to invest in stocks of small-cap, mid-cap, and large-cap companies. The fund employs a quantitative and fundamental analysis with a bottom-up stock picking and asset allocation approach to create its portfolio. It benchmarks the performance of its portfolio against the IFC Investable India Index. The India Fund, Inc. was formed on December 27, 1993 and is domiciled in the Singapore.John Hancock Income Securities Trust NYSE:JHS$11.18 0.00 (-0.04%) Closing price 05/8/2026 03:59 PM EasternExtended Trading$11.18 +0.00 (+0.04%) As of 05/8/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.John Hancock Income Securities Trust is a closed ended fixed income mutual fund launched and managed by John Hancock Investment Management LLC. It is co-managed by John Hancock Asset Management. The fund invests in the fixed income markets of United States. It invests primarily in corporate and government bonds with average maturity of 7.57 years. The fund benchmarks the performance of its portfolios against the Lehman Brothers Government/ Credit Bond Index. John Hancock Income Securities Trust was formed in February 14, 1973 and is domiciled in United States. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/04 - 05/08 SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
